REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,594,207 | -28.9% | 84,305 | -14.7% | 0.00% | -33.3% |
| Q4 2022 | $2,241,827 | +24.2% | 98,846 | +129.5% | 0.00% | +50.0% |
| Q3 2021 | $1,805,000 | +170.6% | 43,067 | +151.0% | 0.00% | +100.0% |
| Q2 2021 | $667,000 | -75.8% | 17,159 | -78.8% | 0.00% | -66.7% |
| Q1 2021 | $2,756,000 | -3.3% | 80,807 | +45.6% | 0.00% | -40.0% |
| Q2 2019 | $2,851,000 | -12.1% | 55,504 | -1.9% | 0.01% | -16.7% |
| Q1 2019 | $3,242,000 | +21.0% | 56,564 | -11.5% | 0.01% | 0.0% |
| Q4 2018 | $2,680,000 | – | 63,894 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |